RECKITTBEN share price
Reckitt Benckiser Bangladesh · Pharmaceuticals & Chemicals · Category A
Price
Closing prices, 19 Nov 2026 Live prices free with an account
- Previous close
- ৳3,217.50
- Day range
- 3,215.00 – 3,219.00
- Volume
- 69
- Turnover
- ৳2.2L
RECKITTBEN price over the last year
Daily closing prices from DSE, not adjusted for bonus or rights issues.
Reported earnings and NAV
| Period | EPS | NAV / share | NOCFPS |
|---|---|---|---|
| FY26 Q3 | 56.86 | 135.96 | 266.68 |
| FY26 Q2 | 41.07 | 79.09 | 153.51 |
| FY26 Q1 | 23.26 | 210.85 | 75.60 |
| FY25 Annual | 172.93 | 187.58 | 170.67 |
| FY25 Q3 | 52.22 | 132.02 | 161.18 |
| FY25 Q2 | 29.71 | 79.80 | 98.13 |
| FY25 Q1 | 32.45 | 383.09 | 79.64 |
| FY24 Annual | 159.17 | 350.64 | 22.55 |
Per-share figures in taka, as published on DSE. Interim EPS is for the period, not annualised.
Latest DSE announcements
-
The company has informed the following being acknowledged by the Board of Directors meeting held on 29 October 2026: Cancellation of old agreements: i. Acknowledged the cancelation of license agreement dated 10 April 2019 and first addendum dated 08 August 2023 between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser (ENA) B.V, The Netherlands with effect from 31 December 2025. Royalty rate was between 3.5% to 5% of the net revenue for the selected brands. (cont.1)
-
(Cont. news of RECKITTBEN): ii. Acknowledged the cancelation of license agreement dated 10 April 2019 and first addendum dated 08 August 2023 between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser Health limited, UK with effect from 31 December 2025. Royalty rate was 6% of the net revenue for the selected brands. Execution of New License Agreements: i. Acknowledged the execution of new license agreement between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser (ENA) B.V, (cont.2)
-
(Cont. news of RECKITTBEN): The Netherlands with effect from 1st January 2026. Royalty rate would be 6% of the net revenue for the selected brands. The agreement will be submitted to BIDA for approval, and they will notify once such approval is obtained. ii. Acknowledged the execution of new license agreement between Reckitt Benckiser (Bangladesh) PLC and (cont.3)
-
(Cont. news of RECKITTBEN): Reckitt Benckiser Health Limited, Uk with effect from 1st January 2026, Royalty rate would be 6% of the net revenue for the selected brands. The agreement will be submitted to BIDA for approval, and they will notify once such approval is obtained. iii. Acknowledged the execution of new license agreement between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser LLC, USA with effect from 1st January 2026. (cont.4)
-
(Cont. news of RECKITTBEN): Royalty rate would be 6% of the net revenue for the selected brands. The agreement will be submitted to BIDA for approval, and they will notify once such approval is obtained. (end)
-
(Q3 Un-audited): EPS was Tk. 56.86 for July-September 2026 as against Tk. 52.22 for July-September 2025; EPS was Tk. 121.20 for January-September 2026 as against Tk. 114.38 for January-September 2025. NOCFPS was Tk. 266.68 for January-September 2026 as against Tk. 161.18 for January-September 2025. NAV per share was Tk. 135.96 as on September 30, 2026 and Tk. 187.58 as on December 31, 2025. (cont.)
Other Pharmaceuticals & Chemicals shares
| Ticker | Price | % | Turnover |
|---|---|---|---|
| ASIATICLABAsiatic Laboratories Limited | 116.70 | +1.83% | ৳16.3Cr |
| WATACHEMWata Chemicals Limited | 183.10 | +8.22% | ৳11.0Cr |
| SQURPHARMASquare Pharmaceuticals PLC. | 209.70 | -0.29% | ৳8.4Cr |
| ACMELABThe ACME Laboratories Limited | 77.50 | -3.73% | ৳3.2Cr |
| ORIONINFUOrion Infusion Ltd. | 202.80 | -0.44% | ৳2.9Cr |
| ACMEPLACME Pesticides Limited | 24.50 | -0.41% | ৳2.8Cr |
RECKITTBEN: common questions
What is RECKITTBEN's share price?
RECKITTBEN closed at ৳3,215 on the Dhaka Stock Exchange (Closing prices, 19 Nov 2026), -2.50 (-0.08%) from the previous close of ৳3,217.50.
What is RECKITTBEN's 52-week high and low?
Between 23 Nov 2025 and 19 Nov 2026, RECKITTBEN traded as high as ৳3,700 and as low as ৳3,181.20 on DSE.
What is RECKITTBEN's P/E ratio?
At ৳3,215, RECKITTBEN's P/E ratio is 18.59, on its FY25 earnings per share of ৳172.93.
What dividend did RECKITTBEN declare?
For 2025, Reckitt Benckiser Bangladesh declared a 730% cash dividend. Percentages are of the ৳10 face value.
Which sector is RECKITTBEN in?
Reckitt Benckiser Bangladesh is listed in the Pharmaceuticals & Chemicals sector of the Dhaka Stock Exchange, in category A.
Prices, trades and company figures are from the Dhaka Stock Exchange; prices are at least 15 minutes old. Trakkr is not affiliated with DSE, and nothing here is investment advice.